Original Source(s)
Related Content
Anticoagulant recalled over life-threatening risk
Contamination in 22 lots of the injection may cause pulmonary embolism or vascular occlusion; no related adverse events reported.
by Mouj Hijazi
October 15, 2026
-
3 min
FDA updates PAH label with trial data
In adults diagnosed with pulmonary arterial hypertension within the previous year, adding sotatercept to background therapy reduced the risk of clinical worsening events by 76% compared with placebo.
September 22, 2026
-
3 min
Menopause may be underdocumented in EHRs
Surveys captured nearly 7 times as many menopause observations as structured clinical records, with high agreement when both sources identified menopause.
September 14, 2026
-
4 min